Announced
Financials
Sources
Tags
Acquisition
Private
Ukraine
Pharmaceuticals
Pending
Single Bidder
pharmaceutical company
Majority
Friendly
Private Equity
Synopsis
STADA Arzneimittel, a global manufacturer of generic drugs and consumer healthcare products, agreed to acquire the pharmaceuticals unit of Horizon Capital-backed Biopharma, a Ukrainian pharmaceutical company. Financial terms were not disclosed. “STADA’s acquisition of the pharmaceutical business of Biopharma is a logical step within STADA’s European growth strategy. We will integrate Ukraine as soon as possible into our European organization,” Steffen Wagner, STADA Head of European Markets.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.